Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

被引：0
|
作者：
Elisabeth E. Fransen van de Putte
Laura S. Mertens
Richard P. Meijer
Michiel S. van der Heijden
Axel Bex
Henk G. van der Poel
J. Martijn Kerst
Andries M. Bergman
Simon Horenblas
Bas W. G. van Rhijn
机构：
[1] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Urology
[2] University Medical Center Utrecht,Department of Urology
[3] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
来源：
World Journal of Urology | 2016年 / 34卷
关键词：
Bladder cancer; Neoadjuvant chemotherapy; Dose dense; MVAC; Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：157 / 162
页数：5
相关论文
共 50 条
  • [1] Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
    van de Putte, Elisabeth E. Fransen
    Mertens, Laura S.
    Meijer, Richard P.
    van der Heijden, Michiel S.
    Bex, Axel
    van der Poel, Henk G.
    Kerst, J. Martijn
    Bergman, Andries M.
    Horenblas, Simon
    van Rhijn, Bas W. G.
    WORLD JOURNAL OF UROLOGY, 2016, 34 (02) : 157 - 162
  • [2] Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience
    Serrano, Marina
    Munoz-Unceta, Nerea
    Alonso, Lucia Andrea
    Azueta, Ainara
    Banos, Jose Luis Gutierrez
    Ferreira, Laura
    Dominguez, Mario
    Zurita, Albero Torres
    Ballestero, Roberto
    Cacho, Diego
    Lopez-Brea, Marta
    Sotelo, Marta
    Campos-Juanatey, Felix
    Barselo, Enrique Ramos
    Duran, Ignacio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (02): : 549 - 553
  • [3] Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience
    Marina Serrano
    Nerea Muñoz-Unceta
    Lucía Andrea Alonso
    Ainara Azueta
    José Luis Gutiérrez Baños
    Laura Ferreira
    Mario Domínguez
    Albero Torres Zurita
    Roberto Ballestero
    Diego Cacho
    Marta López-Brea
    Marta Sotelo
    Félix Campos-Juanatey
    Enrique Ramos Barseló
    Ignacio Duran
    Clinical and Translational Oncology, 2024, 26 : 549 - 553
  • [4] Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Hattori, Yuto
    Fujiwara, Tasuku
    Hagimoto, Hiroki
    Kokubun, Hidetoshi
    Murata, Shiori
    Makita, Noriyuki
    Abe, Yohei
    Kubota, Masashi
    Tohi, Yoichiro
    Tsutsumi, Naofumi
    Shibasaki, Noboru
    Inoue, Koji
    Kawakita, Mutsushi
    Yamasaki, Toshinari
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1102 - 1106
  • [5] Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Urabe, Fumihiko
    Suzuki, Hirotaka
    Iwatani, Kosuke
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1107 - 1107
  • [6] Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Kikuchi, Eiji
    Hayakawa, Nozomi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1106 - 1106
  • [7] Resource utilization and cost efficacy analysis of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (DD-MVAC) versus gemcitabine-cisplatin (GC) as neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC).
    Montazeri, Kamaneh
    Dranitsaris, George
    Curran, Catherine
    Thomas, Jonathan David
    Ingham, Matthew D.
    Preston, Mark A.
    Steele, Graeme S.
    Kilbridge, Kerry L.
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Mossanen, Matthew
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Resource utilization analysis of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (DD-MVAC) versus gemcitabine-cisplatin (GC) as neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC)
    Montazeri, Kamaneh
    Dranitsaris, George
    Curran, Catherine
    Thomas, Jonathan David
    Ingham, Matthew D.
    Preston, Mark A.
    Steele, Graeme S.
    Kilbridge, Kerry L.
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Mossanen, Matthew
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial
    Anari, Fern
    O'Neill, John
    Choi, Woonyoung
    Chen, David Y. T.
    Haseebuddin, Mohammed
    Kutikov, Alexander
    Dulaimi, Essel
    Alpaugh, R. Katherine
    Devarajan, Karthik
    Greenberg, Richard E.
    Bilusic, Marijo
    Wong, Yu-Ning
    Viterbo, Rosalia
    Hoffman-Censitsc, Jean H.
    Lallas, Costas D.
    Trabulsic, Edouard J.
    Smaldone, Marc
    Geynisman, Daniel M.
    Zibelman, Matthew
    Lin, Jianqing
    Kelly, W. Kevin
    Uzzo, Robert
    McConkey, David
    Plimack, Elizabeth R.
    EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (01): : 54 - 60
  • [10] Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer
    Sagaster, P
    Flamm, J
    Flamm, M
    Mayer, A
    Donner, G
    Oberleitner, S
    Havelec, L
    Lepsinger, L
    Ludwig, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1320 - 1324
12345